| Protein FDR Confidence: Combined | Accession | Description | Exp. q-value: Combined | Sum PEP Score | Coverage [%] | # Peptides | # PSMs | # Unique Peptides | # AAs | MW [kDa] | calc. pI | Abundance Ratio: (B Stem KO) / (B Stem WT) | Abundance Ratio (log2): (B Stem KO) / (B Stem WT) | Abundance Ratio P-Value: (B Stem KO) / (B Stem WT) | Abundance Ratio Adj. P-Value: (B Stem KO) / (B Stem WT) | Abundance Ratio Variability [%]: (B Stem KO) / (B Stem WT) | Abundances (Grouped): B Stem KO | Abundances (Grouped): B Stem WT | Abundances (Grouped) CV [%]: B Stem KO | Abundances (Grouped) CV [%]: B Stem WT | Abundances (Scaled): F2: 129, Sample, B Stem KO, 1 | Abundances (Scaled): F2: 130, Sample, B Stem KO, 2 | Abundances (Scaled): F2: 131, Sample, B Stem KO, 3 | Abundances (Scaled): F2: 126, Sample, B Stem WT, 1 | Abundances (Scaled): F2: 127, Sample, B Stem WT, 2 | Abundances (Scaled): F2: 128, Sample, B Stem WT, 3 | Abundances (Normalized): F2: 129, Sample, B Stem KO, 1 | Abundances (Normalized): F2: 130, Sample, B Stem KO, 2 | Abundances (Normalized): F2: 131, Sample, B Stem KO, 3 | Abundances (Normalized): F2: 126, Sample, B Stem WT, 1 | Abundances (Normalized): F2: 127, Sample, B Stem WT, 2 | Abundances (Normalized): F2: 128, Sample, B Stem WT, 3 | Abundance: F2: 129, Sample, B Stem KO, 1 | Abundance: F2: 130, Sample, B Stem KO, 2 | Abundance: F2: 131, Sample, B Stem KO, 3 | Abundance: F2: 126, Sample, B Stem WT, 1 | Abundance: F2: 127, Sample, B Stem WT, 2 | Abundance: F2: 128, Sample, B Stem WT, 3 | Abundances Count: F2: 129, Sample, B Stem KO, 1 | Abundances Count: F2: 130, Sample, B Stem KO, 2 | Abundances Count: F2: 131, Sample, B Stem KO, 3 | Abundances Count: F2: 126, Sample, B Stem WT, 1 | Abundances Count: F2: 127, Sample, B Stem WT, 2 | Abundances Count: F2: 128, Sample, B Stem WT, 3 | Biological Process | Cellular Component | Molecular Function | Pfam IDs | Entrez Gene ID | Gene Symbol | Chromosome | Reactome Pathways | Ensembl Gene ID | KEGG Pathways | WikiPathways | # Razor Peptides | Modifications |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| High | P63078 | Guanine nucleotide-binding protein G(I)/G(S)/G(O) subunit gamma-8 OS=Mus musculus OX=10090 GN=Gng8 PE=3 SV=1 | 0.005 | 3.308 | 23 | 1 | 1 | 1 | 70 | 7.8 | 7.14 | 1.401 | 0.49 | 0.067071449 | 0.540582127 | 22.13 | 114.3 | 85.7 | 16.77 | 19.27 | 130.7 | 93.7 | 108.3 | 81.2 | 108.8 | 77.3 | 17.6 | 12.6 | 14.6 | 10.9 | 14.6 | 10.4 | 15.4 | 12 | 14.6 | 9.7 | 13.7 | 10.1 | 1 | 1 | 1 | 1 | 1 | 1 | regulation of biological process;response to stimulus | membrane | signal transducer activity | Pf00631 | 14709 | Gng8 | 7 | "Glucagon signaling in metabolic regulation; Glucagon-like Peptide-1 (GLP1) regulates insulin secretion; Adrenaline,noradrenaline inhibits insulin secretion; Activation of G protein gated Potassium channels; Vasopressin regulates renal water homeostasis via Aquaporins; Glucagon-type ligand receptors; Inhibition of voltage gated Ca2+ channels via Gbeta/gamma subunits" | ENSMUSG00000063594.5 | Morphine addiction; Cholinergic synapse; Retrograde endocannabinoid signaling; Dopaminergic synapse; Ras signaling pathway; GABAergic synapse; Chemokine signaling pathway; Glutamatergic synapse; Pathways in cancer; Alcoholism; PI3K-Akt signaling pathway; Circadian entrainment; Serotonergic synapse | Chemokine signaling pathway; G Protein Signaling Pathways; Focal Adhesion-PI3K-Akt-mTOR-signaling pathway; Myometrial Relaxation and Contraction Pathways; Calcium Regulation in the Cardiac Cell | 0 |